Literature DB >> 16259005

The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells.

Francis Dodeller1, Alla Skapenko, Joachim R Kalden, Peter E Lipsky, Hendrik Schulze-Koops.   

Abstract

The role of p38 mitogen-activated protein kinase in primary human T cells is incompletely understood. We analyzed in detail the role of p38 in the regulation of effector functions and differentiation of human CD4 T cells by using a p38-specific inhibitor and a dominant-negative mutant of p38. p38 was found to mediate expression of IL-10 and the Th2 cytokines IL-4, IL-5, and IL-13 in both, primary naive and memory T cells. In contrast, inhibition of p38 activity did not affect expression of the Th1 cytokines IFN-gamma and TNF induced by TCR-stimulation, but decreased IL-12-mediated IFN-gamma expression. Cytokine expression from established Th2 effector cells was also regulated by p38, however, the role of p38 was less pronounced compared to primary CD4 T cells. p38 MAPK regulated cytokine gene expression at both, the transcriptional level by activating gene transcription and the post-transcriptional level by stabilizing cytokine mRNA. As a result of the effect of p38 on IL-4 expression, p38 activity modulated differentiation of naive precursor T cells by inducing a shift of the Th1/Th2 balance toward the immuno-modulatory Th2 direction. Together, the data suggest that p38 plays a key role in human Th2 cell immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259005     DOI: 10.1002/eji.200535029

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

Review 1.  The role of the T cell in age-related inflammation.

Authors:  Richard Macaulay; Arne N Akbar; Sian M Henson
Journal:  Age (Dordr)       Date:  2012-01-15

2.  The serine-threonine kinase inositol-requiring enzyme 1α (IRE1α) promotes IL-4 production in T helper cells.

Authors:  Kyeorda L Kemp; Zhenghong Lin; Fang Zhao; Beixue Gao; Jianxun Song; Kezhong Zhang; Deyu Fang
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

3.  p38 MAPK regulates Th2 cytokines release in PBMCs in allergic rhinitis rats.

Authors:  Jie Liu; Lisi Liu; Yonghua Cui; Jian Zhang; Hongqun Jiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

4.  The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway.

Authors:  Hui Peng; Xisheng Wang; Peter F Barnes; Hua Tang; James C Townsend; Buka Samten
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

5.  Alternative ZAP70-p38 signals prime a classical p38 pathway through LAT and SOS to support regulatory T cell differentiation.

Authors:  Jesse E Jun; Kayla R Kulhanek; Hang Chen; Arup Chakraborty; Jeroen P Roose
Journal:  Sci Signal       Date:  2019-07-23       Impact factor: 8.192

6.  Elevating calcium in Th2 cells activates multiple pathways to induce IL-4 transcription and mRNA stabilization.

Authors:  Liying Guo; Joseph F Urban; Jinfang Zhu; William E Paul
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10.

Authors:  Derek D Sloan; Keith R Jerome
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

8.  Overactivation of mitogen-activated protein kinase and suppression of mitofusin-2 expression are two independent events in high mobility group box 1 protein-mediated T cell immune dysfunction.

Authors:  Zhong-qiu Lu; Lu-ming Tang; Guang-ju Zhao; Yong-ming Yao; Xiao-mei Zhu; Ning Dong; Yan Yu
Journal:  J Interferon Cytokine Res       Date:  2013-05-22       Impact factor: 2.607

9.  Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4+CD25high T Cells.

Authors:  Yoshiki Yamamoto; Takaharu Negoro; Rui Tada; Michiaki Narushima; Akane Hoshi; Yoichi Negishi; Yasuko Nakano
Journal:  Biomedicines       Date:  2021-05-29

10.  Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.

Authors:  Sung Nam Park; Kyung Tae Noh; Young-Il Jeong; In Duk Jung; Hyun Kyu Kang; Gil Sun Cha; Su Jung Lee; Jong Keun Seo; Dae Hwan Kang; Tae-Ho Hwang; Eun Kyung Lee; Byungsuk Kwon; Yeong-Min Park
Journal:  Exp Mol Med       Date:  2013-02-08       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.